The causal relation between heterozygous SOX17 variants and PAH was first proposed in 2018 by genome-wide gene burden tests, which enabled the identification of novel gene variants via a comparison of variant frequencies between patients with PAH and controls in the UK NIHR PAH cohort. The gene discussed is SOX17; the disease is pulmonary arterial hypertension.